GvHD Hub (@gvhd_hub) 's Twitter Profile
GvHD Hub

@gvhd_hub

A global online platform providing latest treatment options and medical information in graft-versus-host disease (GvHD). #gvhd
linktr.ee/GraftVersusHost

ID: 926010699993763841

linkhttp://www.gvhdhub.com/ calendar_today02-11-2017 08:58:50

2,2K Tweet

4,4K Takipçi

987 Takip Edilen

GvHD Hub (@gvhd_hub) 's Twitter Profile Photo

📝 Phase III results of the ALLG BM12 CAST trial, presented by David Curtis at #EHA2025, found that the 2-year relapse-free survival was prolonged in the PTCy + CsA group vs CsA + MTX (74% vs 59%; HR, 0.55; p = 0.045). More news: GvHDhub.com #GvHD #aGvHD #cGvHD

📝 Phase III results of the ALLG BM12 CAST trial, presented by David Curtis at #EHA2025, found that the 2-year relapse-free survival was prolonged in the PTCy + CsA group vs CsA + MTX (74% vs 59%; HR, 0.55; p = 0.045).

More news: GvHDhub.com 

#GvHD #aGvHD #cGvHD